Department of Neurosurgery, Fengtai District, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring West Road, Beijing, 100070, China.
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Transl Stroke Res. 2023 Apr;14(2):200-210. doi: 10.1007/s12975-022-01033-4. Epub 2022 May 14.
This study aimed to establish a new scoring model based on the early brain injury (EBI) indicators to predict the 90-day functional outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively enrolled 825 patients and prospectively enrolled 108 patients with aSAH who underwent surgical clipping or endovascular coiling (derivation cohort = 640; validation cohort = 185; prospective cohort = 108) in our institute. We established a logistic regression model based on independent risk factors associated with 90-day unfavorable outcomes. The discrimination of the prognostic model was assessed by the area under the curve in a receiver operating characteristic curve analysis. The Hosmer-Lemeshow goodness-of-fit test and a calibration plot were used to evaluate the calibration of the prediction model. The developed scoring model named "TAPS" (total score, 0-7 points) included the following admission variables: age > 55 years old, WFNS grade of 4-5, mFS grade of 3-4, Graeb score of 5-12, white blood cell count > 11.28 × 10/L, and surgical clipping. The model showed good discrimination with the area under the curve in the derivation, validation, and prospective cohorts which were 0.816 (p < 0.001, 95%CI = 0.77-0.86), 0.810 (p < 0.001, 95%CI = 0.73-0.90), and 0.803 (p < 0.001, 95%CI = 0.70-0.91), respectively. The model also demonstrated good calibration (Hosmer-Lemeshow goodness-of-fit test: X = 1.75, df = 8, p = 0.988). Compared with other predictive models, TAPS is an easy handle tool for predicting the 90-day unfavorable outcomes of aSAH patients, which can help clinicians better understand the concept of EBI and quickly identify those patients at risk of poor prognosis, providing more positive treatment strategies. Trial registration: NCT04785976. Registered 5 March 2021-retrospectively registered, http://www.clinicaltrials.gov .
本研究旨在建立一种基于早期脑损伤(EBI)指标的新评分模型,以预测颅内动脉瘤性蛛网膜下腔出血(aSAH)患者的 90 天功能结局。我们回顾性纳入 825 例 aSAH 患者,并前瞻性纳入我院接受手术夹闭或血管内栓塞的 108 例 aSAH 患者(推导队列=640 例;验证队列=185 例;前瞻性队列=108 例)。我们基于与 90 天不良结局相关的独立危险因素建立了 logistic 回归模型。通过受试者工作特征曲线分析评估预后模型的区分能力。Hosmer-Lemeshow 拟合优度检验和校准图用于评估预测模型的校准。该命名为“TAPS”(总评分,0-7 分)的评分模型纳入了以下入院变量:年龄>55 岁、WFNS 分级 4-5 级、mFS 分级 3-4 级、Graeb 评分 5-12 分、白细胞计数>11.28×10/L 和手术夹闭。该模型在推导、验证和前瞻性队列中的曲线下面积分别为 0.816(p<0.001,95%CI=0.77-0.86)、0.810(p<0.001,95%CI=0.73-0.90)和 0.803(p<0.001,95%CI=0.70-0.91),显示出良好的区分能力。该模型还表现出良好的校准(Hosmer-Lemeshow 拟合优度检验:X=1.75,df=8,p=0.988)。与其他预测模型相比,TAPS 是一种用于预测 aSAH 患者 90 天不良结局的易于操作的工具,可帮助临床医生更好地理解 EBI 概念,并快速识别预后不良风险较高的患者,提供更积极的治疗策略。试验注册:NCT04785976。于 2021 年 3 月 5 日注册-回顾性注册,网址:http://www.clinicaltrials.gov。